Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma

J Thorac Oncol. 2018 Aug;13(8):e150-e152. doi: 10.1016/j.jtho.2018.03.027.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Humans
  • Mutation
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Programmed Cell Death 1 Receptor / genetics
  • Programmed Cell Death 1 Receptor / immunology
  • Thymoma / drug therapy*
  • Thymoma / genetics*
  • Thymoma / immunology
  • Thymus Neoplasms / drug therapy*
  • Thymus Neoplasms / genetics*
  • Thymus Neoplasms / immunology
  • Thymus Neoplasms / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • pembrolizumab